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MEASUREMENT AND CORRELATION OF
INFLAMMATORY MEDIATORS IN SERUM AND SYNOVIAL
FLUID FROM A CROSS-SECTIONALOSTEOARTHRITIS
COHORT
K. Ma1, S. Visvanathan1, P.A. Marsters1, M. Mascelli1,
X-y. Song2, S. Lohmander3, S. Blake1, F. Baribaud1
1Centocor R&D Inc, Radnor, PA; 2Ethicon R&D Inc, Somerville,
NJ; 3Dept. of Orthopedics, Clinical Sciences Lund, Sweden
Purpose: Evaluate the use of multiplex immunodetection assays
to measure a broad range of inﬂammatory mediators in a cross-
sectional osteoarthritis cohort. Examine relationships between
markers in serum and synovial ﬂuid.
Methods:A cross-sectional cohort composed of 6 sub-groups in-
cluding healthy volunteers (REF n=23), patients with either acute
pyrophosphate arthritis (APA n=17), anterior cruciate ligament
rupture isolated or combined with another ligament (LI n=146),
meniscal tear (MT n=70), osteochondral fracture (OC n=19), pri-
mary knee osteoarthritis (OA n=46) for a total of 321 patients.
One sample of knee synovial ﬂuid (SF) and serum (S) at 1 time
point, varying between 0 days and 26 years after knee injury
or onset of symptoms, were analyzed. Analytes measured us-
ing the Luminex platform were cytokines/chemokines, adipokines
and acute phase proteins (LINCOplex assays, Millipore). Tukey’s
multiple comparison testing was used for all statistical analyses
on logarithmic-transformed marker values.
Results: The intra- and inter-assay variability was below 10 and
20% respectively in both S and SF. The dynamic range of the
standard curves spanned over a 4 logarithm range with cor-
relation coefﬁcients of at least 0.9 for all analytes tested with
exception of SAP, which in S had a correlation coefﬁcient of 0.84.
Data validation was determined by spiking recovery experiments
at 6 concentrations over a 3 logarithm range using 70-130%
recovery as acceptability criteria. As a result, at least 75% of the
patient samples had data that could be utilized for analysis from
19 analytes (IL-1α, IL-4, IL-6, IL-7, CXCL8/IL-8, IL-10, IL-12p70,
IL-17A, CCL11/Eotaxin, GM-CSF, CXCL10/IP-10, CCL2/MCP-
1, CCL3/MIP-1α, TNFα, resistin, adiponectin, CRP, SAA, and
SAP) for S and 11 analytes (IL-6, CXCL8/IL-8, CXCL10/IP-10,
CCL2/MCP-1, CCL5/RANTES, act-PAI-1, resistin, adiponectin,
CRP, SAA, and SAP) for SF. At least half of the patients had
an additional 5 analytes (IL-2, IL-13, IL-15, IFNγ, act-PAI-1) for
S and 3 analytes (IL-1α, IL-10 and Leptin) for SF available for
analysis. For the 12 analytes measured in both matrices a ma-
jority had higher measured median levels in S than SF. However,
this trend was reversed for IL-6 in the APA and OA groups, for
IL-10, CXCL10/IP-10, and resistin in the APA group, for act-PAI-1
across all groups, and for CCL2/MCP-1 for the LI, MT and OC
groups. Three analytes (IL1α, CRP, SAA) were correlated be-
tween S and SF levels (r=0.619, 0.590 and 0.577 respectively).
CRP and SAA also correlated with each other both in S and SF
(r=0.815 and 0.713 respectively), as did IL1α and IL4 (r=0.689
and 0.741). Another 20 pairs of analytes correlated (r>0.6) in S
and 5 in SF. IL-7, an inﬂammatory mediator inducing osteoclasto-
genesis, correlated in S with GM-CSF, IL-17A and CCL3/MIP-1α
(r=0.700, 0.633 and 0.615). All 3 markers correlated with each
other (rGM-CSF:CCL3/MIP-1α =0.792, rGM-CSF:IL-17=0.737) and with IL-
6 (rGM-CSF:IL-6=0.671, rCCL3/MIP-1α: IL-6=0.678, rIL-17:IL-6=0.639). All
correlation pairs identiﬁed did so across all subgroups, irrespec-
tive of sampling time after injury or OA score.
Conclusions: Three multiplex kits were validated for their use
in measuring markers in S and SF from a cross-sectional OA
cohort. Data from 24 and 14 analytes from S and SF respectively
were collected for at least 50% of all samples assayed. A wide
range of concentrations was found for all analytes across all
sub-groups in the cohort. Finally, several markers correlated with
each other whether in S or SF.
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OSTEOCHONDRAL INJURY INCREASES TYPE II
COLLAGEN DEGRADATION PRODUCTS (C2C) IN
SYNOVIAL FLUID OF THOROUGHBRED RACEHORSES
A.B. Scarbrough, M.P. Brown, T.N. Trumble
University of Florida, Gainesville, FL
Purpose: To investigate the effects of exercise and osteochon-
dral (OC) injury on type II collagen degradation (C2C) in synovial
ﬂuid (SF) from Thoroughbred (TB) racehorses and to compare
these results with radiographic and arthroscopic scores of sever-
ity of joint injury.
Methods: SF samples were obtained from 3 groups of TB race-
horses: (1) Rested: 20 TB horses (age range 14 to 20 months),
conﬁrmed normal by clinical and radiographic examination. SF
samples were collected from metacarpophalangeal (MCP) joints
(n=20) and middle (n=14) or radiocarpal joints (n=6) of these
horses before the start of race training. (2) Exercised: horses
from the rested group (group 1) had the same joints sampled at
the end of 5 to 6 months of training. (3) OC injury: 28 Thorough-
bred horses (age range 2 to 7 years) undergoing MCP (n=13),
metatarsophalangeal (MTP; n=1), middle carpal (n=9), or radio-
carpal (n=5) arthroscopic surgery for removal of (OC) fragments,
which were injuries resulting from racing. For group 3, radio-
graphic and arthroscopic scores were determined. SF samples
were assayed using a commercially available ELISA (C2C, IBEX
Technologies, Inc). Differences between groups were determined
by one-way ANOVA and a post hoc Tukey’s multiple-comparison
test. Positive and negative predictive value of SF C2C for identify-
ing OC injury was determined by Fisher’s exact test. Correlations
were determined using the Spearman correlation. P < 0.05 was
considered signiﬁcant.
Results: SF C2C concentrations in OC injured carpal and
MCP/MTP joints were signiﬁcantly different than rested and exer-
cised joints (P < 0.01) (Figure 1). However, carpal and MCP/MTP
SF C2C concentrations were not signiﬁcantly different between
rested and exercised groups. Arthroscopic scores were signiﬁ-
cantly higher for OC injured carpal than OC injured MCP/MTP
Figure 1. Horizontal scatter plot of SF C2C concentrations for MCP/MTP (top)
and carpal (bottom) joints in rested, exercised, and OC injured TB racehorses.
The short vertical solid lines represent the mean value for each group. The ver-
tical dashed lines represent SF concentrations (≥ 64 pmol/mL for MCP/MTP
joints and ≥ 75 pmol/mL for carpal joints) for which there is predictive value in
discriminating OC injured horses from rested or exercised horses. Like letters
represent no signiﬁcant difference.
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joints (P=0.004). OC injured SF C2C concentrations were posi-
tively correlated with radiographic scores (R=0.43; P=0.03) and
arthroscopic scores (R=0.52; P=0.03). Arthroscopic scores were
positively correlated with radiographic scores (R=0.51; P=0.04).
SF C2C concentrations ≥ 64 pmol/mL for MCP/MTP joints and ≥
75 pmol/mL for carpal joints were arbitrarily chosen to determine
predictive value for discriminating OC injured horses from rested
or exercised horses. This yielded a positive predictive value of
73% and a negative predictive value of 94% for the MCP/TP
joints, and positive predictive value of 79% and negative predic-
tive value of 95% for the carpus.
Conclusions: OC injury caused a signiﬁcant increase in SF
C2C concentrations in carpal and MCP/MTP joints compared
to rested and exercised horses. SF C2C concentrations were
correlated to severity of joint injury. Based on these ﬁndings, SF
C2C analysis may be useful for evaluation of joint injury.
Acknowledgment: Study supported in part by the University of
Florida Equine Soundness Program.
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FOLLOW-UP OF COLL2-1, COLL2-1NO2 AND
MYELOPEROXYDASE SERUM LEVELS IN MARATHON
RUNNERS
M. Deberg1, A. Labasse1, C. Sanchez1, A. Bosseloir2,
Y. Henrotin1
1University of Liège, Liège, Belgium; 2Zentech, Liège, Belgium
Purpose: To determine the inﬂuence of marathon on the serum
levels of two markers of cartilage degradation, Coll2-1, a peptide
of type II collagen triple helix, and its nitrated form, Coll2-1NO2,
and of a marker of neutrophils activation, the myeloperoxidase
(MPO).
Methods: Coll2-1, Coll2-1NO2 and MPO were measured by
speciﬁc immunoassays in 66 marathon runners without joint
pain and aged in mean of 47 (min: 31 - max: 59) years. Sera
were taken before and after the marathon. All the subjects were
submitted to a questionnaire concerning their physical activity
(i.e. training or best performance) and their life style (i.e; diet).
The total running distance was 42 km. Their performance in the
marathon was ranged from 149 to 270 min.
Results: Before the marathon, the Coll2-1 and Coll2-1NO2 val-
ues were not affected by age, body mass index, sex and per-
formance [Coll2-1 median: 90.66 (28.77-234.68) nM and Coll2-
1NO2 median: 0.16 (0.05-0.71) nM], while MPO levels were
higher in female [median: 41.3 (29.90-96.50) ng/ml] than in
male [median: 33.00 (15.60-84.60) ng/ml] (p<0.05). After the
marathon, Coll2-1 levels were slightly decreased [median: 76.63
(28.89-185.06) nM], Coll2-1NO2 levels were unmodiﬁed [median:
0.15 (0.05-0.61) nM] and MPO levels were doubled [median:
71.80 (31.50-172.10) ng/ml] compared to the pre-marathon val-
ues [MPO median: 34.20 (15.60-96.50) ng/ml] (p<0.001). The
variation of MPO during the marathon was negatively correlated
with the training time per week (r=-0.36; p=0.0045). Before the
marathon, there was no correlation between the different biolog-
ical markers (Coll2-1, Coll2-1NO2 and MPO).
Conclusions: Coll2-1 and Coll2-1NO2 serum levels were not
modiﬁed by marathon, suggesting that, at least at short-term,
this intensive physical activity does not signiﬁcantly modiﬁed
cartilage metabolism. Interestingly, serum MPO levels were in-
creased after the marathon and training reduced this elevation.
These results suggest that neutrophils were activated during the
marathon and that training reduces neutrophils activation during
the marathon.
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QUANTITATIVE WESTERN BLOTTING SHOWS
DIFFERENCES IN SYNOVIAL FLUID AGGRECAN
FRAGMENT PATTERNS BETWEEN HUMAN JOINT
DISEASES
A. Struglics, S. Larsson, M. Hansson, S. Lohmander
Lund University, Lund, Sweden
Purpose: Aggrecan proteolysis is an early key event in arthritis.
Aggrecanases cleave the interglobular domain of aggrecan re-
leasing N-terminal ARGS fragments, and the chondroitin sulfate
rich domain releasing C-terminal G3 domain fragments. Several
reports suggest a role for more than one ADAMTS activity and
possibly other proteases in the release of aggrecan fragments
from joint cartilage. Differences between animal models and hu-
man disease, and differences between human joint diseases
and disease stages suggest a role for a method to map in detail
aggrecan proteolytic fragments in multiple samples. We have
developed a quantitative Western blot method for analysis of
aggrecan fragment patterns in synovial ﬂuids (SF) from patients
with different joint diseases.
Methods: Dissociative CsCl gradient centrifugation was used
for sample preparation from SF of 5 knee-healthy subjects (ref-
erence) and 27 patients with 4 different knee joint diseases.
Aggrecan fragments (D1-fractions) separated by SDS-PAGE and
transferred to PVDF membranes were screened, using a digi-
tal luminescence imager, with an ARGS neo-epitope antibody
or an antibody recognizing the G3-domain. ARGS-standards
were generated by complete aggrecanase digestion of intact hu-
man aggrecan. Quantiﬁcation was by co-running either ARGS-
standards or a control sample (in G3 quantiﬁcation) on each
SDS-gel. Results were compared and expressed as mol (ARGS)
or relative AU (G3) per mg glycosaminoglycan (GAG) determined
by Alcian Blue precipitation.
Results: GAG recovery in D1-fractions was >75%, and West-
ern blot CVs between experiments for anti-ARGS and anti-G3
were 19% and 28%. Total ARGS fragment quantity in SF sam-
ples by Western blot correlated well with ARGS-ELISA (R2=0.87,
n=19), while the correlation between ARGS and GAG content
was only moderate (R2=0.31, n=31). SFs contained two major
ARGS-bands, ARGS-SELE and ARGS-GVED, and three major
G3-bands (GRGT-G3, GLGS-G3 and AGEG-G3) as a result of
aggrecanase proteolysis. Median values of total ARGS fragments
in the diagnostic groups were signiﬁcantly higher in the acute
arthritis and acute injury groups compared to the reference,
and these SF samples contained the highest total ARGS values
per mg GAG (Table 1; *P<0.05; **P<0.01 compared to refer-
ence). The differential between reference and disease groups
was greatest for the ARGS-SELE fragment. Median values of
total G3 per mg GAG were signiﬁcantly lower in the acute arthri-
tis and osteoarthritis groups than in the reference. The ratios of
total-ARGS to total-G3 fragments varied markedly between the
diagnostic groups.
Table 1. Western blot analysis in diagnostic groups. Median values normalized
to reference
Group n ARGS- ARGS- Total Total Total
SELE GVED ARGS G3 ARGS/G3
Reference 5 1 1 1 1 1
Acute arthritis 8 25** 10.1** 10.7* 0.5* 22.3*
Acute injury 9 20.2** 10.2** 10* 0.6 9.5**
Chronic injury 5 4.2 2.2 2.1 1.2 0.9
Osteoarthritis 5 8.4 2.9 3.4 0.3* 2.6
Conclusions: We have developed a quantitative Western blot
method for aggrecan fragment screening of synovial ﬂuids. It
provides reliable results as judged by relatively low CV and good
correlation between Western and ELISA methods. Anti-ARGS
